Cabazitaxel (JEVTANA)

Cabazitaxel is a chemotherapy medicine approved for treatment of patients that have failed standard chemotherapy. It is a member of a class of medications called taxanes. Cabazitaxel is administered intravenously in combination with oral prednisone. Cabazitaxel kills cancer cells by blocking cell division which results in cancer cell death.